We would love to hear your thoughts about our site and services, please take our survey here.
Where did you get your info from that the biggy 51 million was a buy? Risky Pete and i had it on Sqaredeal ,looks like it was a sell and weve been shafted.
Rorker Do not take this as gospel but i have read that one shgare is a signal for big volumes to go through. It was six individual transactions for 1 share but 5 dissapeared.
Its definitely a buy the 52 million .ive just topped up.
I told you something was happening. Dip your bread quick
Marshgad ,i would not like to guess on the price post takeover . Suffice to say you would be smiling. This one is the top volume of the day presently and something is obviously in the air.
Huge volumes yesterday and now Daily Express today, the guy that tipped HML says that rumours of a deal with a Danish Company (imminent Deal according to advfn). If he's half as right then were laughing
No mathematics to it Cynic,these are on the upward march. The train keeps stopping to let off a few but the big money stays in.Just look at the size of trades in and out. Start worrying when the millions are being sold.
No way hit limit these are heading for 8p
oVER TEN MILLION SHRES IN 6 TRADES THIS AFTERNOON
iGTL HEAVY BUYING IM IN FOR THE RIDE
Has anybody any views why the price has not risen. On the trades page the whole page is green with buys all around the 11p mark but no price movement?
Im with debbie on this one
Nearly every day something positive is put out in a RNS or media report but little action withe price . DYOR as i think it will hike upo very soon.
Somebody must knoiw why this share is on the upward move
WKS seems to be todays share
Im also in HmL but you no what they say dont put all your eggs in one basket. 50% would do me nicely
Remember my name and remember i tried to tell you all about this company. Heres another snippet. Bridgewell the broker says buy Allergy Therapeutics (LSE: AGY.L - news) (158p fair value price) Reiterated on yahoo finance yesterday.
Allergy Therapeutics plc, the specialty pharmaceuticals company focused on allergy vaccines, will announce interim results for the six months ended 31 December 2005 on 27th March 2006. An analyst presentation will be held at 9.30am on 27th March 2006
Have a look at this one . LONDON (ShareCast) - Allergy Therapeutics (LSE: AGY.L - news) received a boost today after the hay fever treatment outfit passed a key phase III clinical efficacy and safety trial for its ragweed allergy vaccine. The initial results of the study demonstrated that Pollinex Quattro Ragweed was well tolerated and significantly reduced clinical symptoms compared with a placebo, said the group. "The treatment schedule and speed of action of this ultra short course therapy should translate into rapid acceptance," said Dr Piyush Patel, principle scientist for the study. The Pollinex Quattro allergy vaccines, which require only four injections per year, have the potential to transform allergy treatment for the estimated 30m or more people in North America suffer from allergies to ragweed, the company added. Allergy Therapeutics' R&D director Dr Tom Holdich said, "This is the climax of all the pre-phase III work that we have conducted over the last year and probably the most important data that we have generated in the last 5 years." "North America is now firmly in our sights. It's a fantastic shot in the arm." For more breaking company and market news, visit the Digital Look News Channel Date: Friday 24 Mar 2006 LONDON (ShareCast) - Allergy Therapeutics received a boost today after the hay fever treatment outfit passed a key phase III clinical efficacy and safety trial for its ragweed all
It seems everybody on this board missed out on this baby . The SP rocketed from 13 -52 in little under 45 mins near the close. Although iii board discussed it heavily. Rumour is for similar tomorrow .GOOD LUCK